For Institutional Investors in the US
We believe in the sharing of expert insight for better investment and business decisions. We call this ethos Knowledge Shared.
Access to Medicine: The Need for Innovation, Partnerships and Data Capture
How pharmaceutical companies are addressing the issue of inequitable access to medicine.
Subscribe for relevant insights delivered straight to your inbox
The complexities of the economic recovery have led to an ongoing push-pull in equity markets.
Exploring the strong recovery potential for travel and leisure industries as COVID restrictions ease.
Perspective on some of the major “known unknowns” confronting institutional investors as we step into 2021.
Evaluating growth stocks in the face of concentrated market leadership.
Considering the long-term view on the most expensive mid-cap stocks.
Secular growth leadership will likely continue, with the current crisis only helping these stocks strengthen their advantage.
Director of Research Carmel Wellso explains how disruption in multiple sectors has led to a wide valuation gap.